Moreover, this study is the first to report the prognostic value of ezrin expression in tumours representing all stages and grades, whereby reduced ezrin expression was found to be associated with a significantly reduced 5-year OS in both examined cohorts, and with a significantly reduced DSS in cohort II. Here, EZR is linked to neoplasm.